Kim H, Nathwani B N, Rappaport H
Cancer. 1980 Mar 15;45(6):1379-99. doi: 10.1002/1097-0142(19800315)45:6<1379::aid-cncr2820450617>3.0.co;2-#.
In order to investigate the natural history of so-called "Lennert's lymphoma" and to reevaluate whether non-Hodgkin's lymphoma with a high content of epithelioid histiocytes represents a clinicopathologic entity, we reviewed the histopathologic and clinical features of 60 patients in whom pretreatment diagnostic tissues had shown a diffuse and florid epithelioid histiocytic reaction identical to that originally described by Lennert and Mestdagh. Our study indicates that so-called "Lennert's lymphoma" is a heterogeneous group of disorders, which, in our series, included Hodgkin's disease (27 patients), non-Hodgkin's lymphoma (24 patients), angioimmunoblastic lymphadenopathy (1 patient), and atypical lymphoepithelioid cell proliferations of uncertain etiology and pathogenesis (8 patients). Most of the patients with Hodgkin's disease had Stage I or II disease without B symptoms, whereas patients with non-Hodgkin's lymphoma usually had Stage III or IV disease, commonly with B symptoms. The median survival was 79 months in the Hodgkin's disease group, compared with 12 months in patients with non-Hodgkin's lymphoma (P less than 0.0001). In patients with atpical lymphoepithelioid cell proliferations, the survival pattern was unpredictable, and the number of patients was too small for a meaningful statistical comparison. Progression to malignant lymphoma in 1 of the 8 patients with atypical lymphoepithelioid cell proliferations, however, underscores the malignant potential of this disorder. One patient with angioimmunoblast lymphadenopathy had generalized disease and constitutional symptoms. In Hodgkin's disease with a prominent epithelioid histiocytic reaction, the gross and microscopic features were similar to those observed in Hodgkin's disease in which this reaction was lacking. In non-Hodgkin's lymphoma, however both the macroscopic and microscopic features differed from those of the usual non-Hodgkin's lymphomas. Moreover, subdivision into poorly differentiated lymphocytic, mixed, and histiocytic types did not reveal any differences in median survival among these subtypes. Non-Hodgkin's lymphoma with a multifocal epithelioid histiocytic reaction previously included in the heterogeneous group called "Lennert's lymphoma" appears to be a distinct clinicopathologic entity.
为了研究所谓“ Lennert淋巴瘤”的自然病史,并重新评估上皮样组织细胞含量高的非霍奇金淋巴瘤是否代表一种临床病理实体,我们回顾了60例患者的组织病理学和临床特征,这些患者治疗前的诊断组织显示出与Lennert和Mestdagh最初描述的相同的弥漫性和丰富的上皮样组织细胞反应。我们的研究表明,所谓的“ Lennert淋巴瘤”是一组异质性疾病,在我们的系列研究中,包括霍奇金病(27例)、非霍奇金淋巴瘤(24例)、血管免疫母细胞性淋巴结病(1例)以及病因和发病机制不明的非典型淋巴上皮样细胞增殖(8例)。大多数霍奇金病患者为Ⅰ期或Ⅱ期疾病,无B症状,而非霍奇金淋巴瘤患者通常为Ⅲ期或Ⅳ期疾病,常伴有B症状。霍奇金病组的中位生存期为79个月,而非霍奇金淋巴瘤患者为12个月(P< .0001)。在非典型淋巴上皮样细胞增殖患者中,生存模式不可预测,且患者数量过少,无法进行有意义的统计学比较。然而,8例非典型淋巴上皮样细胞增殖患者中有1例进展为恶性淋巴瘤,这突出了该疾病的恶性潜能。1例血管免疫母细胞性淋巴结病患者有全身疾病和全身症状。在具有显著上皮样组织细胞反应的霍奇金病中,大体和显微镜特征与无此反应的霍奇金病中观察到的相似。然而,在非霍奇金淋巴瘤中,宏观和微观特征均与常见的非霍奇金淋巴瘤不同。此外,细分为低分化淋巴细胞型、混合型和组织细胞型后,这些亚型的中位生存期未显示出任何差异。先前包含在称为“ Lennert淋巴瘤”的异质性组中的具有多灶性上皮样组织细胞反应的非霍奇金淋巴瘤似乎是一种独特的临床病理实体。